Atlas Trials

A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

Clinical trial NCT06457503 · RECRUITING

Trial details

NCT number
NCT06457503
Sponsor
Coherus Oncology, Inc.
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Nasopharyngeal Cancer Recurrent
Start date
2024-11-01
Primary completion
2027-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.